Papers in JHEP Reports
Page 9 · newest first
- Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosisJHEP Reports · 2025
- Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancerJHEP Reports · 2025
- Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activityJHEP Reports · 2025
- Deep learning can predict cardiovascular events from liver imagingJHEP Reports · 2025
- Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinomaJHEP Reports · 2025
- Safety, efficacy, and outcomes of invasive coronary angiography in liver transplant candidatesJHEP Reports · 2025
- Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidenceJHEP Reports · 2025
- Single-cell analysis of mature hepatocytes reveals an IRF1-driven restriction of HDV infectionJHEP Reports · 2025
- C/EBPβ–VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLDJHEP Reports · 2025
- ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signallingJHEP Reports · 2025
- Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseJHEP Reports · 2025
- The association between childhood obesity and major adverse liver outcomes in adolescence and young adulthoodJHEP Reports · 2025
- Temporal dichotomy of neutrophil function in acute liver injury and repairJHEP Reports · 2025
- Regional variations and trends in liver transplantation practices across EuropeJHEP Reports · 2025
- Identification of pediatric MASLD using insulin resistance indicesJHEP Reports · 2025
- DHCR7 inhibition ameliorates MetALD and HCC in mice and human 3D liver spheroidsJHEP Reports · 2025
- Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinomaJHEP Reports · 2025
- Inflammation in MASLD progression and cancerSHILAP Revista de lepidopterología · 2025
- The dual role of TIGIT in regulatory and effector T cells in chronic liver diseaseSHILAP Revista de lepidopterología · 2025
- Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLDJHEP Reports · 2025
- Pediatric to adult care transfer in rare liver diseases: Recommendations based on insights from a European omnistakeholder eventSHILAP Revista de lepidopterología · 2025
- Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infectionJHEP Reports · 2025
- p53 and TIGAR promote redox control to protect against metabolic dysfunction-associated steatohepatitisJHEP Reports · 2025
- Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosisJHEP Reports · 2025
- EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implicationsJHEP Reports · 2025
- Deep learning empowered gadolinium-free contrast-enhanced abbreviated MRI for diagnosing hepatocellular carcinomaJHEP Reports · 2025
- Ischemia-free liver transplantation improves long-term outcomes in a 5-year follow-up studyJHEP Reports · 2025
- Regulatory T cell therapy in autoimmune liver disease and transplantationJHEP Reports · 2025
- Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survivalJHEP Reports · 2025
- Impact of cardiometabolic risk factors on hepatic fibrosis and clinical outcomes in MASLD: A population-based multi-cohort studySHILAP Revista de lepidopterología · 2025
- Proinflammatory macrophages release CXCL5 to regulate T cell function and limit effects of αPD-1 in steatosis-driven liver cancerJHEP Reports · 2025
- Sex-based disparities in liver transplantation: Evidence from a nationwide Italian cohortJHEP Reports · 2025
- Macrophage-derived IL-15 imprints peritoneal TRM-like CD8 T cells in cirrhosis and spontaneous bacterial peritonitisJHEP Reports · 2025
- Lipidomics-based plasma signature of alcohol-related hepatitis linked to short-term mortalityJHEP Reports · 2025
- A novel in vitro system for simultaneous infections with hepatitis B, C, D and E virusesJHEP Reports · 2025
- Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-responseJHEP Reports · 2025
- Impact of age on clinical outcomes among patients with hepatocellular carcinoma: A systematic review and meta-analysisJHEP Reports · 2025
- Thyroid dysfunction in MASLD: Results of a nationwide studyJHEP Reports · 2025
- Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatmentJHEP Reports · 2025
- Towards precision medicine strategies using plasma proteomic profiling for suspected gallbladder cancer: A pilot studyJHEP Reports · 2025
- Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLDSHILAP Revista de lepidopterología · 2025
- Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCCJHEP Reports · 2025
- AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomesJHEP Reports · 2025
- Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinomaJHEP Reports · 2025
- Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinomaJHEP Reports · 2025
- Associations between fruit and vegetable consumption and HCC occurrence in patients with cirrhosisJHEP Reports · 2025
- Liver fibrosis progression analyzed with AI predicts renal declineJHEP Reports · 2025
- Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trialJHEP Reports · 2025
- Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studiesJHEP Reports · 2025
- Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trialsJHEP Reports · 2025